Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Charles River Laboratories International Inc shares valued at $61,000 were purchased by Joseph LaPlume on Aug 22 ’25. At $152.50 per share, Joseph LaPlume acquired 400 shares.
Also, LaPlume Joseph W sold 800 shares, netting a total of over 126,080 in proceeds. Following the sale of shares at $157.60 each, the insider now holds 24,116 shares.
Before that, WALLMAN RICHARD F had added 22,500 shares to its account. In a trade valued at $3,420,000, the Former Director bought Charles River Laboratories International Inc shares for $152.00 each.
As published in a research note from Jefferies on September 09, 2025, Charles River Laboratories International Inc [CRL] has been rated up from a Hold to a Buy and the price target has been revised to $195. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early July. As of May 23, 2025, Redburn Atlantic has increased its “Neutral” rating to a “Buy” for CRL. Earlier on May 14, 2025, TD Cowen upgraded its rating. Their new recommendation was “a Buy” for CRL stock which previously was a “a Hold”.
Analyzing CRL Stock Performance
On last trading session, Charles River Laboratories International Inc [NYSE: CRL] rose 4.22% to $159.74. The stock’s lowest price that day was $153.525, but it reached a high of $159.78 in the same session. During the last five days, there has been a drop of approximately -1.58%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -15.10%. Shares of the company reached a 52-week high of $193.56 on 01/07/25 and a 52-week low of $91.86 on 04/11/25.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
According to the 24-hour chart, there is a support level at 155.58, which, if violated, would cause prices to drop to 151.43. In the upper region, resistance lies at 161.84. The next price resistance is at 163.94. RSI (Relative Strength Index) is 49.70 on the 14-day chart, showing neutral technical sentiment.
Is Charles River Laboratories International Inc subject to short interest?
Stocks of Charles River Laboratories International Inc saw a sharp rise in short interest on 2025-08-29 jumping by 0.48 million shares to 2.67 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 2.19 million shares. A jump of 18.08% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.93 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.93.
Which companies own the most shares of Charles River Laboratories International Inc (CRL)?
In terms of Charles River Laboratories International Inc share price expectations, FactSet research, analysts set an average price target of 195 in the next 12 months, up nearly 27.23% from the previous closing price of $153.27. Analysts anticipate Charles River Laboratories International Inc stock to reach 195 by 2025, with the lowest price target being 195. In spite of this, 9 analysts ranked Charles River Laboratories International Inc stock as Buy at the end of 2025. On May 08, 2025, Evercore ISI assigned a price target of “an Outperform” to the stock and upgraded coverage with a $170.
